226 Chapter 8 REFERENCES 1. Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic — implementation issues and future challenges. Nature Reviews Clinical Oncology. 2021;18(5):297-312. 2. Levine DA, Getz G, Gabriel SB, Cibulskis K, Lander E, Sivachenko A, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67-73. 3. Costas L, Onieva I, Pelegrina B, Marin F, Carmona Á, López-Querol M, et al. Evaluation of Somatic Mutations in Urine Samples as a Noninvasive Method for the Detection and Molecular Classification of Endometrial Cancer. Clinical Cancer Research. 2023:OF1-OF10. 4. Pelegrina B, Paytubi S, Marin F, Martínez JM, Carmona Á, Frias-Gomez J, et al. Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer. eBioMedicine. 2023;94. 5. Ezendam NPM, de Rooij BH, Kruitwagen R, Creutzberg CL, van Loon I, Boll D, et al. ENdometrial cancer SURvivors’ follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial. Trials. 2018;19(1):227. 6. Tranberg M, Jensen JS, Bech BH, Andersen B. Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays. BMC Infectious Diseases. 2020;20(1):926. 7. van den Helder R, Steenbergen RDM, van Splunter AP, Mom CH, Tjiong MY, Martin I, et al. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection. Clinical Cancer Research. 2022;28(10):2061-8. 8. Van Keer S, Latsuzbaia A, Vanden Broeck D, De Sutter P, Donders G, Doyen J, et al. Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study. Journal of Clinical Virology. 2022;155:105271. 9. Schaafsma M, van den Helder R, Bleeker MCG, Rosier-van Dunné F, van der Avoort IAM, Steenbergen RDM, et al. Experiences and preferences towards collecting a urine and cervicovaginal self-sample among women attending a colposcopy clinic. Prev Med Rep. 2022;26:101749. 10. van der Aalst CM, Ten Haaf K, de Koning HJ. Implementation of lung cancer screening: what are the main issues? Transl Lung Cancer Res. 2021;10(2):1050-63. 11. IJzerman MJ, de Boer J, Azad A, Degeling K, Geoghegan J, Hewitt C, et al. Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late. Diagnostics (Basel). 2021;11(1). 12. Marchetti A, Palma JF, Felicioni L, De Pas TM, Chiari R, Del Grammastro M, et al. Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients. Journal of Thoracic Oncology. 2015;10(10):1437-43. 13. Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, Liu MC, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Annals of Oncology. 2020;31(6):745-59.
RkJQdWJsaXNoZXIy MjY0ODMw